Physiotherapeutic conduct in amyotrophic lateral sclerosis
- PMID: 17322959
- PMCID: PMC11068274
- DOI: 10.1590/s1516-31802006000600011
Physiotherapeutic conduct in amyotrophic lateral sclerosis
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a fatal progressive neurodegenerative disease with multifactorial etiology for which, so far, there is no effective medicinal treatment. However, by means of kinesiotherapy intervention and patient guidance and care, physiotherapy can delay physical functional losses, muscle fatigue and immobility of the joint-muscle system, thereby improving the quality of life. This survey had the aim of reviewing the physiotherapeutic conduct currently used in ALS cases. Monthly monitoring is recommended, with changes in goals and conduct at each stage of the disease, activities to be pursued around the home, and emphasis on stretching, muscle strengthening, posture adequacy and respiratory kinesiotherapy.
Esclerose lateral amiotrófica (ELA) é uma doença neurodegenerativa progressiva, fatal, de etiologia multifatorial e sem tratamento medicamentoso efetivo até o momento. Entretanto, a fisioterapia, por meio de intervenções cinesioterapêuticas e orientações aos pacientes e aos cuidadores, ameniza a perda físicofuncional, a fadiga muscular e a imobilidade do sistema músculo-esquelético, melhorando a qualidade de vida. Buscou-se neste trabalho sugerir os procedimentos fisioterapêuticos utilizados atualmente na ELA. Indica-se realizar acompanhamentos mensais com mudanças nos objetivos e nas condutas a cada fase da doença e propõe-se acompanhamento das atividades em domicílio, com ênfase em alongamentos, fortalecimento muscular, adequação postural e cinesioterapia respiratória.
Conflict of interest statement
References
-
- Wicklund MP. Amyotrophic lateral sclerosis: possible role of environmental influences. Neurol Clin. 2005;23(2):461–484. - PubMed
-
- Belsh JM. Diagnostic challenges in ALS. Neurology. 1999;53(8 Suppl 5):S26–S30. discussion S35-6. - PubMed
-
- Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003;63(2):83–101. - PubMed
-
- Kirby J, Halligan E, Baptista MJ, et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain. 2005;128(Pt 7):1686–1706. - PubMed
-
- Shipe C, Zivkovic SA. Electrodiagnostic evaluation of motor neuron disorders. Am J Electroneurodiagnostic Technol. 2004;44(1):30–36. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
